2023 Q3 Form 10-Q Financial Statement
#000178162923000012 Filed on July 14, 2023
Income Statement
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
Revenue | $5.999K | $10.60K | |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $561.00 | ||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $75.00K | $75.47K | $6.542K |
YoY Change | 753.87% | 1053.68% | 34.19% |
Operating Profit | -$69.01K | ||
YoY Change | |||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $44.90K | $44.90K | |
YoY Change | |||
Pretax Income | -$69.01K | -$64.88K | $6.542K |
YoY Change | 685.58% | -1091.68% | 34.19% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$69.01K | -$64.88K | -$6.542K |
YoY Change | 685.58% | 891.68% | 34.19% |
Net Earnings / Revenue | -1150.28% | -612.15% | |
Basic Earnings Per Share | -$0.02 | -$0.02 | $0.00 |
Diluted Earnings Per Share | -$0.02 | ||
COMMON SHARES | |||
Basic Shares Outstanding | 4.328M shares | 4.328M shares | 4.258M shares |
Diluted Shares Outstanding | 4.328M shares |
Balance Sheet
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $355.00 | $3.956K | $7.692K |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | $20.10K | $10.00K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $55.51K | $93.91K | $164.5K |
YoY Change | 1237.32% | -42.91% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $248.3K | $255.2K | $60.61K |
YoY Change | 16.95% | 321.11% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $55.51K | $93.91K | $164.5K |
Total Long-Term Assets | $248.3K | $255.2K | $60.61K |
Total Assets | $303.8K | $349.2K | $225.1K |
YoY Change | 40.36% | 55.1% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $167.5K | ||
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $565.5K | $541.9K | $232.6K |
YoY Change | 143.03% | 132.97% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | |||
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | |||
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $565.5K | $541.9K | $232.6K |
Total Long-Term Liabilities | |||
Total Liabilities | $565.5K | $541.9K | $232.6K |
YoY Change | 143.03% | 132.97% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $297.3K | $228.3K | $43.06K |
YoY Change | 473.44% | 430.16% | |
Common Stock | $4.328K | $4.328K | $4.328K |
YoY Change | 0.0% | 0.0% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$261.7K | -$192.7K | -$7.470K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $303.8K | $349.2K | $225.1K |
YoY Change | 40.36% | 55.1% |
Cashflow Statement
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$69.01K | -$64.88K | -$6.542K |
YoY Change | 685.58% | 891.68% | 34.19% |
Depreciation, Depletion And Amortization | $561.00 | ||
YoY Change | |||
Cash From Operating Activities | |||
YoY Change | |||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | |||
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | |||
Cash From Investing Activities | |||
Cash From Financing Activities | |||
Net Change In Cash | |||
YoY Change | |||
FREE CASH FLOW | |||
Cash From Operating Activities | |||
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001781629 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--11-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
usd | ||
ankm |
Project
Project
|
usd | ||
ankm |
Increase Decrease In Right Of Use Assets And Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLiabilitiesNet
|
usd | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
usd | ||
us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
usd | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | ||
us-gaap |
Interest Paid
InterestPaid
|
usd | ||
us-gaap |
Interest Paid
InterestPaid
|
usd | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | ||
CY2023Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-05-31 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
333-255392 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
ANKAM INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
61-1900749 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
5348 Vegas Drive | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Las Vegas | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NV | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
89108 | ||
dei |
City Area Code
CityAreaCode
|
136 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
12325001 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
No | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2023Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
4327996 | shares |
CY2023Q2 | us-gaap |
Cash
Cash
|
3956 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
2277 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
4800 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
10000 | usd |
CY2023Q2 | us-gaap |
Assets Net
AssetsNet
|
79956 | usd |
CY2022Q4 | us-gaap |
Assets Net
AssetsNet
|
169752 | usd |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
93912 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
176829 | usd |
CY2023Q2 | us-gaap |
Development In Process
DevelopmentInProcess
|
198710 | usd |
CY2022Q4 | us-gaap |
Development In Process
DevelopmentInProcess
|
198710 | usd |
CY2023Q2 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
56536 | usd |
CY2022Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
70491 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
349158 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
446030 | usd |
CY2023Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
85600 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
123499 | usd |
CY2023Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
4080 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
4000 | usd |
CY2023Q2 | us-gaap |
Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
|
374717 | usd |
CY2022Q4 | us-gaap |
Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
|
215017 | usd |
CY2023Q2 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
77460 | usd |
CY2022Q4 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
149660 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
541857 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
492176 | usd |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | ||
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4327996 | shares |
CY2023Q2 | us-gaap |
Liabilities
Liabilities
|
541857 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
492176 | usd |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4327996 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4327996 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4327996 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4327996 | shares |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
4328 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4328 | usd |
CY2023Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
31262 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
31262 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
228289 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
81736 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
192699 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
46146 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
349158 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
446030 | usd |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
10598 | usd |
us-gaap |
Revenues
Revenues
|
13698 | usd | |
CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
62980 | usd |
CY2022Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1713 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
125963 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4725 | usd | |
CY2023Q2 | us-gaap |
Professional Fees
ProfessionalFees
|
5516 | usd |
CY2022Q2 | us-gaap |
Professional Fees
ProfessionalFees
|
4268 | usd |
us-gaap |
Professional Fees
ProfessionalFees
|
20333 | usd | |
us-gaap |
Professional Fees
ProfessionalFees
|
10768 | usd | |
CY2023Q2 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
6978 | usd |
CY2022Q2 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
561 | usd |
us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
13955 | usd | |
us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
1122 | usd | |
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
75474 | usd |
CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
6542 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
160251 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
16615 | usd | |
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-64876 | usd |
CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-6542 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-146553 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-16615 | usd | |
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-64876 | usd |
CY2022Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-6542 | usd |
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-146553 | usd | |
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-16615 | usd | |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4257739 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4327996 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3818448 | shares | |
CY2021Q4 | us-gaap |
Shares Issued
SharesIssued
|
3250000 | shares |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-23195 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
967000 | shares |
CY2022Q1 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
29010 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10073 | usd |
CY2022Q1 | us-gaap |
Shares Issued
SharesIssued
|
4217000 | shares |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4258 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
110996 | shares |
CY2022Q2 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
3330 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6542 | usd |
CY2022Q2 | us-gaap |
Shares Issued
SharesIssued
|
4327996 | shares |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-7470 | usd |
CY2022Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
4327996 | shares |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-46146 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-81677 | usd |
CY2023Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
4327996 | shares |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-127823 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-64876 | usd |
CY2023Q2 | us-gaap |
Shares Outstanding
SharesOutstanding
|
4327996 | shares |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-192699 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-146553 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-16615 | usd | |
us-gaap |
Amortization And Depreciation Of Decontaminating And Decommissioning Assets
AmortizationAndDepreciationOfDecontaminatingAndDecommissioningAssets
|
13955 | usd | |
us-gaap |
Amortization And Depreciation Of Decontaminating And Decommissioning Assets
AmortizationAndDepreciationOfDecontaminatingAndDecommissioningAssets
|
1122 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
4800 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-10000 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
3265 | usd | |
ankm |
Project
Project
|
156810 | usd | |
ankm |
Increase Decrease In Right Of Use Assets And Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLiabilitiesNet
|
17596 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
37899 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-167500 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
80 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
158021 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1538 | usd | |
us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
55000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
55000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
32340 | usd | |
us-gaap |
Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
|
159700 | usd | |
us-gaap |
Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
|
31013 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
159700 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
63353 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1679 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
6815 | usd | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2277 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
877 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3956 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7692 | usd |
us-gaap |
Revenue Recognition Allowances
RevenueRecognitionAllowances
|
<p id="xdx_84B_eus-gaap--RevenueRecognitionAllowances_z8ZgpafFmON3" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline"><span id="xdx_86A_z0chc2wWUDsg">Revenue Recognition</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company offers a newsletter subscription, which contains the most significant news in the cryptocurrency market. In most cases identified articles show price changes, experts opinions, technical information that can be used to understand the market and make right decisions in this area.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: center">10<br/> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>ANKAM</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: center"><b>NOTES TO THE FINANCIAL STATEMENTS</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: center"><b>As of May 31, 2023</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: center">(Unaudited)</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) No. 2014-09, <i>"Revenue from Contracts with Customer"</i>. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 1: Identify the contract with a customer</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 2: Identify the performance obligations in the contract</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 3: Determine the transaction price</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 4: Allocate the transaction price to the performance obligations in the contract</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">The Company collects payment from customers before the service is provided. If deposits are collected before the service is provided, the Company recognizes deferred revenue.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84C_eus-gaap--UseOfEstimates_zEjap79HZvn" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline"><span id="xdx_86A_zQ9oZEHKcC59">Use of Estimates</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> | ||
CY2023Q2 | ankm |
Server Agreement
ServerAgreement
|
79956 | usd |
CY2022Q4 | ankm |
Server Agreement
ServerAgreement
|
169752 | usd |
CY2023Q2 | us-gaap |
Debt Current
DebtCurrent
|
374717 | usd |
CY2022Q4 | us-gaap |
Debt Current
DebtCurrent
|
215017 | usd |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
228289 | usd | |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
81736 | usd | |
us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-228289 | usd | |
us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-81736 | usd | |
CY2023Q2 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
47940 | usd |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
17165 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
47940 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
17165 | usd |